Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
暂无分享,去创建一个
K. Rau | Tae-You Kim | Joong-Won Park | C. Yen | A. Cheng | H. Pan | H. Lim | Z. Ren | S. Qin | J. Kim | B. Ryoo | Dongli Zhou | Ho Yeong Lim | H. Choi | J. Straub | K. Berghoff | J. Scheele